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Abstract 
Objective  The protozoan Toxoplasma gondii expresses large amounts of a 37 kDa Type 2C 
serine-threonine phosphatase, the so-called TgPP2C which has been suggested to contribute to parasite 
growth regulation. Ectopic expression in mammalian cells also indicated that the enzyme could regulate 
growth and survival. In this study, we aimed to investigate the interaction of TgPP2C with human SSRP1 
(structure-specific recognition protein 1) and the effects of TgPP2C on cell viability. 
Methods  The yeast two hybrid system, His-tag pull-down and co-immunoprecipitation assays were 
used to confirm the interaction of TgPP2C with SSRP1 and determine the binding domain on SSRP1. The 
evaluation of cell apoptosis was performed using cleaved caspase-3 antibody and Annexin-V/PI kit 
combined with flow cytometry. 
Results  We identified human SSRP1 as an interacting partner of TgPP2C. The C-terminal region of 
SSRP1 including the amino acids 471 to 538 was specifically mapped as the region responsible for 
interaction with TgPP2C. The overexpression of TgPP2C down-regulated cell apoptosis and negatively 
regulated apoptosis induced by DRB, casein kinase II (CKII) inhibitor, through enhanced interaction with 
SSRP1. 
Conclusion  TgPP2C may be a parasitic factor capable of promoting cell survival through interaction 
with the host protein SSRP1, thereby creating a favorable environment for parasite growth. 
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INTRODUCTION 
n eukaryotes, PP2C is one of the four major 
conserved serine/threonine phosphatases 
(PP1, PP2A, PP2B, and PP2C)
[1-2]
. At least 15 
different gene products of PP2C have been identified 
in human that encode the superfamily of PP2Cs, 
which seems to arise following a series of duplication 
events
[3]
. PP2C family members play critical roles in 
cell survival and apoptosis regulation
[4]
. The majority 
of them are involved in regulation of stress activated 
protein kinase (SAPK) cascades
[5]
 at different levels 
of the pathway. For example, PP2Cα, PP2Cβ, PP2Cε, 
and Wip1 have been shown to negatively regulate cell 
apoptosis by inhibiting SAPK signaling pathways
[6-9]
. In 
contrast, PP2Cα and PP2Cβ promoted cell apoptosis 
of neuronal and endothelial cells
[10]
, whereas 
PP2Cδ/ILKAP promoted cancer cell apoptosis by 
stimulating TNFα-induced signaling pathways
[4]
. On 
the other hand, the PP2C superfamily is also 
associated with eukaryotic cell cycle processes in 
particular by controlling the CDKs phosphorylation 
status
[11-12]
. Wip1 can dephosphorylate p53 and 
negatively regulates the p36-p53 pathway mediating 
the cell cycle arrest and apoptosis induced by UV 
irradiation
[13]
. In yeast, it has been reported that the 
overexpression of Ptc2 and Ptc3 may, by the 
dephosphorylating Rad53, relieve cell division arrest 
caused by DNA damage
[14]
. These results suggested a 
positive role of PP2C family on cell survival. 
Toxoplasma gondii (T. gondii) is a protozoan 
eukaryote member of the Apicomplexa phylum. It is 
an obligate intracellular parasite which can cause 
anthropozoonosis of various severities and can be 
even lethal in immuno-suppressed hosts. The 
tachyzoite stage of T. gondii invades and develops in 
any nucleated cell. Previous studies showed that T. 
gondii infection protected its host cells from 
apoptosis induced by multiple apoptotic stimuli, 
including UV or gamma irradiation, growth factor 
scarcity, IL-2 deprivation, and exposure to toxins
[15-16]
. 
The precise mechanism by which the parasite 
establishes such anti-apoptotic condition in the host 
cells remains unclear. However, it has been 
suggested that a phosphatase of T. gondii might be 
involved in the establishment of the anti-apoptotic 
condition in a variety of cell types
[17]
. In extracellular 
and intracellular tachyzoites, previous studies have 
pinpointed that type 2C protein phosphatases 
represent the major type of serine threonine 
phosphatase activities: two molecular species have 
been shown to be particularly abundant and called 
hnPP2C
[18]
 and TgPP2C
[19]
. While hnPP2C is secreted 
into the cytoplasm of the host cells and translocate 
to the host nucleus during infection
[18]
, there are 
data supporting TgPP2C being secreted as well (our 
unpublished data). In addition, ectopic expression in 
mammalian cells shows that TgPP2C interferes with 
the cell activity by promoting G2/M arrest. 
Collectively, these data prompted us to investigate 
the physiological role of TgPP2C in the host cell, 
particularly its possible involvement in the regulation 
of cell apoptosis.  
In order to assess the physiological functions of 
TgPP2C in host cells, we have previously used yeast 
two hybrid system to identify the cellular proteins 
interacting with it (our unpublished data). One of the 
candidate proteins is SSRP1 (structure-specific 
recognition protein), initially identified as a 
cisplatin-modified DNA binding protein and played 
an important role in the regulation of gene 
replication and transcription
[20]
. SSRP1 was required 
for cell viability and early embryonic development
[21]
. 
This feature incited us to investigate if the potential 
interaction between these two proteins could be 
important for the determination of cell fate. 
In this study, we reported SSRP1 as an 
interacting partner of TgPP2C. The interaction has 
been initially identified in Yeast two-hybrid system 
and then confirmed by the biochemical approaches. 
We also determined that the C terminal region of 
SSRP1 as sufficient to promote the interaction with 
the phosphatase, and provided evidence that 
TgPP2C-SSRP1 interaction is important for the 
control of cell fate.  
MATERIALS AND METHODS 
Cell Culture and Transfection 
HeLa cells (Cell Resource Center, Institute of Life 
Science Chinese Academy of Sciences, Shanghai, 
China) were cultured in Dulbecco’s modified Eagle 
medium (DMEM, Gibco BRL, Grand island, NY) 
supplemented with 10% fetal bovine serum (PAA 
Laboratories, Linz, Austria), 1% penicillin/strep- 
tomycin (Genom, China) at 37 °C in a humidified 
atmosphere containing 5% CO2. Cells at 80%-90% 
conﬂuence in a 6-well plate were transfected with  
2 μg of DNA using Lipofectamin 2000 according to 
the manufactor (Invitrogen, Carlsbad, CA). 
Yeast Strain 
The yeast strain L40 (MATa leu2 his3 trp1 ade2 
I 
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GAL4 gal80, LYS2::(lexAop)4-HIS3 URA3::(lexAop)s- 
lacZ) was provided by Dr. Serge Benichou. The yeast 
was grown at 30 °C in either YPAD 
(Yeast Extract-Peptone-Adenine-Dextrose) medium 
or SC-Leu-Trp (synthetic complete yeast growth 
medium lacking leucine and tryptophan) medium to 
maintain plasmids. 
Construction of Hybrid Plasmids for Yeast 
Two-hybrid Study 
The full length cDNA of TgPP2C were amplified 
by PCR from HA-TgPP2C (provided by Dr. Isabelle 
Tardieux at Université Descartes of France) using the 
primers (forward: 5’-CAGGAATTCGGATGAAGTCCTC 
TGCTGAAATT-3’, reverse: 5’-GTGCTCGAGGCTAATC 
AGTCTTCTTGAAG-3’) and cloned in-frame into 
XhoI-EcoRI sites in the yeast expression vector 
pLEX12. The entire or truncated versions of SSRP1 
were amplified by PCR from pCDNA3.1-SSRP1 
(provided by Prof. Hua Lu at Indiana University of 
Indiana) using the following appropriate primers 
flanked by appropriate restriction sites and ligated 
in-frame into the yeast expression vector pGAD-GE. 
The primers for pGAD-GE-SSRP1 are 5’-TTACTCG 
AGTATGGCAGAGACACTGGAGTTC-3’ and 5’-TGTTCTA 
GAAACTACTCATCGGATCCTGACGC-3’; and the rest- 
riction enzymes for it are XbaI and XhoI. The primers 
for pGAD-GE-N-SSRP1 are 5’-GTCGGATCCATATGGCA 
GAGACACTGGAGTTC-3’ and 5’-GAACTCGAGGACTAC 
AGACGCAGTACTGTGGT-3’; and the restriction 
enzymes for it are BamHI and XhoI. The primers for 
pGAD-GE-M-SSRP1 are 5’-CTCGAATTCCCCTACACCAC 
AGTACTGCGT-3’ and 5’-GCTTCTAGACGCTATCCTGAG 
TCATCGCTGCT-3’; and the restriction enzymes for it 
are EcoRI and XbaI. The primers for pGAD- 
GE-C-SSRP1 are 5’-CAGGAATTCAGCGATGACTCAGGA 
GAAGAAG-3’ and 5’-TTACTCGAGGTCTACTCATCGGA 
TCCTGAC-3’; and the restriction enzymes for it are 
EcoRI and XhoI. The primers for pGAD-GE-C1-SSRP1 
are 5’-CAGGAATTCAGCGATGACTCAGGAGAAGAAG-3’ 
and 5’-TTACTCGAGAGCTACACCTCCACAGGCTTCTT-3’; 
and the restriction enzymes for it are EcoRI and XhoI. 
The primers for pGAD-GE-C2-SSRP1 are 5’-CAGGAA 
TTCAAGAAGGGCAAAGACCCCAAT-3’ and 5’-GGACTC 
GAGAGCTAATATTCTTTCATGGCT-3’; and the restric- 
tion enzymes for it are EcoRI and XhoI. The primers 
for pGAD-GE-C3-SSRP1 are 5’-TATGAATTCGAAGGG 
GGCCGAGGCGAGTCT-3’ and 5’-TTACTCGAGGTCTACT 
CATCGGATCCTGAC-3’; and the restriction enzymes 
for it are EcoRI and XhoI. The yielded hybrid plasmids 
were then verified by DNA sequencing. The yeast 
expression vector pLEX12 carried the BD fusion and 
the TRP1 marker. The yeast expression vector 
pGAD-GE carried the AD fusion and the LEU2 
marker. 
Yeast Two-hybrid Analysis of Protein-protein 
Interaction 
Two hybrid plasmids were introduced into the 
yeast strain L40 by the lithium acetate 
transformation. Transformants were grown on 
SC-Leu-Trp (synthetic complete yeast growth 
medium lacking leucine and tryptophan) selective 
medium at 30 °C for 2 to 3 d. The produced colonies 
were picked and patched onto a single SC-Leu-Trp 
plate. After incubation for 18 h at 30 °C, the colonies 
on this plate were transferred to the YPAD plate 
containing a nylon membrane (Shanghai Bandao 
Industrial Co., Ltd., China) and incubated for 24 h at 
30 °C for the X-gal (5-bromo-4-chloro-3- indolyl-β-D- 
galactopyranoside) assay. 
X-gal Assay  
X-gal assay was used to examine the expression 
of the lacZ reporter gene in L40 yeast reporter strain. 
Briefly, the nylon membrane with the patches of 
yeast was carefully removed from the surface of the 
YPAD plate, frozen in liquid nitrogen for 30 s, and 
then placed on a plate containing X-gal solution (for 
each membrane, 10 mg X-gal was dissolved in 100 µL 
DMF, 60 µL 2-mercaptoethanol and 10 mL Z buffer). 
The covered plate was then incubated at 37 °C to 
check for the appearance of blue color and monitor 
the β-Galactosidase enzyme activity over a 24 h 
period. 
Construction, Expression and Purification of 
His-TgPP2C Fusion Protein  
Construction of pBAD-His-TgPP2C expression 
vector: the full length TgPP2C was amplified by PCR 
from HA-TgPP2C plasmid and inserted into pBAD-His 
A vector (kindly provided by Prof. Xuesong Sun of 
Jinan University, China) with XhoI and HindIII to 
construct the pBAD-His-TgPP2C recombinant 
expression vector. The PCR primers were 5’-GTCCTC 
GAGAAGTCCTCTGCTGAAATT-3’ and 5’-GCGAAGCT 
TGCCTAATCAGTCTTCTTGAAC-3’. The presence of the 
insert in frame was verified by DNA sequencing. 
His-TgPP2C fusion protein was expressed in E. coli 
BL21 after induction with 20% L-arabinose for 8 h at 
25 °C. To subsequently purify pBAD-His- TgPP2C, 
bacteria were resuspended in lysis buffer A      
[50 mmol/L Tris-HCL, pH7.6, 150 mmol/L NaCl, 
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1% Triton X-100, 1% protease inhibitor cocktail 
(Roche), 2 mmol/L PMSF] containing 100 μg/mL 
lysozyme. Bacterial extracts were sonicated for   
20 min and centrifuged at 12,000 rpm for 30 min at   
4 °C to remove cell debris. His-TgPP2C fusion protein 
was purified from supernatant of bacterial lysates by 
affinity chromatography using Ni-NTA Superflow 
according to the manufactor (Qiagen). The 
concentration of purified protein was quantified by a 
BCA assay (Beyotime Biotechnology, China).  
His-tag Pull-down Assay 
Pull-down assay was performed to assess the 
interaction of His-tagged TgPP2C protein with the 
target proteins in HeLa cells. To prepare cell lysate 
for His-tag pull-down assay, untreated HeLa cells  
or 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole 
(DRB, Sigma, St. Louis, MO) -treated cells       
(100 μmol/L, 6 h) were harvested and resuspended 
in ice-cold lysis buffer A for 30 min on ice. Then, the 
cell suspension was centrifuged at 13,200 rpm for   
30 min at 4 °C. The protein concentration was 
determined by BCA protein assay kit. 
The cell extract was precleared by incubation 
with 20 μL of 50% Ni-NTA Superflow for 20 min twice 
at 4 °C on a rocker. The precleared supernatants 
(500 μg of proteins) were then incubated with 
Ni-NTA Superflow beads coated or not with 
His-TgPP2C (30 μg) respectively for 4 h at 4 °C on a 
rocker. After brief centrifugation, the beads were 
washed four times with lysis buffer A, resuspended 
and boiled in SDS-PAGE sample buffer. Then, the 
fractions bound to Ni-NTA Superflow or His-TgPP2C 
were subjected to SDS-PAGE and analyzed by 
standard immunoblotting using specific mouse 
monoclonal antibody against SSRP1 (Clone10D1, 
BioLegend). The levels of recombinant His-TgPP2C 
proteins used were analyzed by His (AB102-01, 
Tiangen, China) antibody or CBB (Coomassie Brilliant 
Blue) staining of SDS-PAGE gels. 
Co-immunoprecipitation Assay 
Pellets of cell were lysed in buffer B         
(20 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 
1% Triton X-100, sodium pyrophosphate, 
β-glycerophosphate, EDTA, Na3VO4, leupeptin, and 
1% protease inhibitor cocktail (Roche). The extracts 
were precleared with 20 μL protein A/G-agarose 
(Santa Cruz) and 1 μg mouse IgG on a rocker at 4 °C 
for 30 min. After that, the precleared supernatant 
were incubated with the mouse monoclonal HA 
antibody (H9658, Sigma) at 4 °C overnight with 
gentle agitation. The immune complexes were then 
analyzed by immunoblotting using specific 
antibodies against HA and SSRP1 as described below. 
Western Blot Analysis 
The level of cleaved caspase-3 were analyzed by 
Western blotting in HeLa cells expressing HA-TgPP2C 
and/or treated with DRB (100 μmol/L, 6 h). Whole 
cell extracts were prepared with the lysis buffer B. 
The same amounts of protein samples (as 
determined by a BCA assay) were separated by 10% 
SDS/PAGE, electrophoresed and transferred onto a 
PVDF membrane. Blots were probed with the 
Cleaved Caspase-3 antibody (Cell Signaling 
Technology), mouse monoclonal HA antibody 
(H9658, Sigma), and mouse monoclonal GAPDH 
antibody (ZS-25778, ZSGB-BIO, China) at 4 °C 
overnight with gentle agitation. Standard 
immunoblotting protocol was performed. The 
visualization of all immunoblot detections were 
performed with horseradish peroxidase-conjugated 
secondary antibodies (ProteinTech Group) 
and enhanced chemiluminescence (ECL kit, Beyotime. 
Biotechnology, China). 
Flow Cytometry 
For FACS (ﬂuorescence-activated cell sorting) 
analysis, HeLa cells were transiently transfected with 
HA-TgPP2C and/or treated with DRB (100 μmol/L,  
6 h). After trypsin/EDTA harvest and PBS washes, the 
cells were stained with Alexa Fluor 488 Annexin-V/PI 
(HH-V13241, Invitrogen) following the protocol of 
the manufacturer. Annexin V has a high affinity for 
phospholipid-like phosphatidylserine (PS) and is a 
widely used marker of cell apoptosis
[22]
. Propidium 
iodide (PI), can only intercalate the double-stranded 
DNA upon loss of membrane integrity and is a good 
marker of cell viability. Flow cytometry was 
performed using a FACS Calibure (BD Biosciences) 
flow cytometer with laser excitation at 488 nm. 
Fluorescence emission collection of Alexa Fluor 488 
and of PI was through a 530/30 nm and 585/42 nm 
filters, respectively. The data were analyzed using 
Flowjo software. Only living cells profiled using 
forward scatter (FSC) and side scatter (SSC) were 
counted. A minimum of 10,000 cells within the gated 
region were analyzed. 
Statistics Analysis 
Data from the rate of apoptosis are expressed as 
mean±SEM of three independent experiments. 
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Statistical analysis was performed using Student’s 
paired t-test and the statistical significance was 
defined as P<0.05. 
RESULTS 
SSRP1 is a Candidate Partner of TgPP2C Identified 
by Yeast two Hybrid (Y2H) System 
Hybrid plasmids pLEX12-TgPP2C and 
pGAD-GE-SSRP1 were co-transformed into yeast 
reporter strain L40. The interaction was analyzed by 
the X-gal assay. As indicated by the blue color of the 
yeast patches in Figure 1A, LexBD-TgPP2C fusion 
protein interacted with GAD-SSRP1 fusion protein 
(yeast patches group 1). Yeasts co-transformed 
either with the two empty vectors (yeast patches 
group 2), or each of the two recombinant vectors 
plus another empty vector (yeast patches groups 3 
and 4) were used as negative controls, while those 
co-transformed with pGAD-Ras and pLEX12-Raf 
(yeast patches group 5) were used as positive control. 
TgPP2C Interacts with SSRP1 in vitro and in HeLa 
Cells 
We next checked whether the Y2H result could 
 
be confirmed at the protein level by assessing the 
interaction between SSRP1 and TgPP2C. To this end, 
we performed His-tag pull-down assays using 
immobilized recombinant His-TgPP2C. Affinity 
pull-down assay showed that TgPP2C interacted 
specifically with SSRP1 from extract of HeLa cells 
(Figure 1B). For co-immunoprecipitation assay, HeLa 
cells were transfected with HA-TgPP2C or HA-vector 
plasmids, respectively. Cells expressing the 
corresponding HA fusion protein and HA polypeptide 
(Figure 1C) were lyzed and incubated with anti-HA 
antibody. The immune complexes resulting from the 
co-immunoprecipitation with anti-HA antibody was 
examined by Western blot analysis. As shown in 
Figure 1C, endogenous SSRP1 of HeLa cells was 
co-precipitated with HA-TgPP2C by anti-HA antibody 
in HA-TgPP2C-overexpressed cells whereas in cells 
transfected by HA-vector, no SSRP1 was found in the 
immune complex. 
Mapping of the Binding Domain in SSRP1 for its 
Interaction with TgPP2C 
Next, we tried to identify the binding domain of 
SSRP1 for its interaction with TgPP2C. Three 
truncated peptides of SSRP1 have been constructed, 
corresponding respectively to the N-terminal region 
 
Figure 1. TgPP2C interacted with human SSRP1. (A) TgPP2C-SSRP1 interaction in yeast two hybrid 
system. Yeasts were transformed by various combinations of plasmids as indicated and analyzed by 
X-gal assays as described in Materials and methods. Interaction of the two proteins is shown by the 
blue color of the yeast patches. (B) TgPP2C-SSRP1 interaction in His-tag pull-down assay. HeLa cell 
lysates were incubated either with Ni-NTA Superflow beads alone (1), or with Ni-NTA beads coated with 
His-TgPP2C (2) respectively for 4 h at 4 °C. After brief centrifugation, the beads were washed with lysis 
buffer A, resuspended and boiled in SDS-PAGE sample buffer. Then, the pull-down fractions, together 
with the lysates (Lysates) were analyzed by Western blotting with antibodies specific to SSRP1 and His. 
(C) TgPP2C-SSRP1 interaction demonstrated by co-immunoprecipitation assay. HeLa cells transfected 
with HA-vector or HA-TgPP2C plasmids were harvested for assay. After preclearing by incubation with 
20 μL protein A/G-agarose and 1 μg mouse IgG at 4 °C for 30 min, HeLa cell lysates were incubated with 
the mouse monoclonal HA antibody at 4 °C overnight. Total lysates and the immune complexes were 
analyzed by Western blotting with the specific antibodies. All results are representative of at least three 
repeated experiments. 
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(amino acids 1-242, N-SSRP1), the middle region 
(235-475, M-SSRP1), and the C-terminal region 
(471-709, C-SSRP1) of the SSRP1 protein (Figure 2A). 
These truncated peptides of SSRP1 were fused with 
Gal4 AD in pGAD-GE vector, and analyzed by X-gal 
assays in two hybrid system for their binding to 
LexBD-TgPP2C. As shown in Figure 2B, only the 
C-terminal amino acids 471-709 (pGAD-C-SSRP1) 
interacted with pLEX12-TgPP2C. Subsequently, the 
C-terminal region (471-709, C-SSRP1) of SSRP1 was 
subdivided into three smaller fragments (Figure 2A), 
and tested similarly using yeast two hybrid system. 
The X-gal assay showed that the amino acids 
471-538 of SSRP1 (C1-SSRP1) was responsible for its 
interaction with TgPP2C (Figure 2C). 
TgPP2C Negatively Regulated Cell Apoptosis 
 In order to identify the biological function of 
TgPP2C, especially its role in cell apoptosis, we 
tested the effects of TgPP2C expression on the 
apoptosis rate of HeLa cells. The cell death rate was 
measured by flow cytometry. The Figure 3A was a 
representative result of three repeated experiments. 
The results in Figure 3A and 3B demonstrated that 
the expression of TgPP2C in HeLa cells significantly 
reduced the cell death rate, suggesting that the 
parasitic PP2C might have an inhibitory effect on the 
apoptosis of cells. 
TgPP2C Nnegatively Regulated DRB-induced Cell 
Apoptosis Probably by Interaction with SSRP1 
It has been reported that CKII kinase is 
necessary for viability and animal embryo- 
genesis
[23-24]
. Inhibition of CKII activity with a specific 
inhibitor DRB
[25-26]
 induced cell apoptosis
[27-28]
. 
Furthermore, the Serine 510 residue of SSRP1, 
whose phosphorylation by CKII is important for its 
DNA-binding activity, is located in the C1-SSRP1 
region (amino acids 417-538) responsible for its 
interaction with TgPP2C
[29]
. Therefore, we asked if 
TgPP2C-SSRP1 interaction may be involved in 
DRB-induced apoptosis, and if the phosphorylation of 
 
 
Figure 2. Mapping of TgPP2C binding domain in SSRP1 using yeast two-hybrid system. (A) A schematic 
presentation of SSPR1 truncated peptide fragments. The grey boxes represent the full-length SSRP1 and 
SSPR1 truncated peptides capable of binding to TgPP2C, and the white box represent those incapable 
of interaction with TgPP2C. 
*
: Serine 510 of SSRP1, a target site for CKII phosphorylation. (B) X-gal 
analysis of interaction between TgPP2C and the N-, M-, and C-SSRP1 fragments. (C) The interactions of 
TgPP2C with C1-, C2-, and C3-SSRP1 fragments. All results are representative of at least three repeated 
experiments. 
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SSRP1 by CKII could impact on PP2C-SSRP1 
interaction. To this end, we tested first whether the 
expression of TgPP2C in HeLa cells may affect the 
apoptosis induced by DRB treatment. HeLa cells 
transfected with HA-tagged TgPP2C expression 
vector or empty vector were treated with or without 
100 μmol/L DRB for 6 h. A fraction of these cells was 
lysed and subjected to Western blotting analysis to 
examine the activation level of caspase-3, the 
marker of cell apoptosis. As shown in Figure 4A, in 
cells treated with DRB, in comparison with control 
(DMSO treated) cells, the level of the cleaved 
caspase-3 was dramatically increased (lane 2 
compared to lane 1), indicating a higher level of 
activation of this enzyme and an apoptotic state of 
the cells. Interestingly, in cells expressing TgPP2C, 
the cleavage of caspase-3 by DRB treatment was 
significantly reduced compared to cells without 
TgPP2C expression (lane 3 compared to lane 2). This 
result suggested that the expression of TgPP2C in 
the cells may have an inhibitory effect on cell 
apoptosis induced by DRB. In order to confirm this 
result, another half of the cells treated with DRB 
were subjected to flow cytometry analysis to assess 
the death rate of cells. Our results clearly 
demonstrated that the expression of TgPP2C in HeLa 
cells inhibit the cell apoptosis induced by DRB, and 
that the expression of TgPP2C exerted an inhibitory 
effect on cell apoptosis (Figure 4B, 4C).  
Next, we tested if DRB could affect the binding 
between TgPP2C and SSRP1. His-tag pull-down 
assays have been performed using His-PP2C 
recombinant protein purified with Ni-NTA Superflow 
nickel columns, and incubated with cell lysates from 
HeLa cells treated or not previously with 100 μmol/L 
DRB. The results in Figure 4D demonstrated that 
TgPP2C-SSRP1 interaction was significantly increased 
by DRB treatment, suggesting that the phosphoryla- 
tion of SSRP1 by CKII might inhibit its interaction with 
TgPP2C. Giving that the Serine 510 on SSRP1, which is 
a target site for CKII phosphorylation, is located in 
the binding domain for TgPP2C interaction, it would 
be possible that its phosphorylation might bother 
the interaction with TgPP2C. 
DISCUSSION 
Despite the considerable progress made by 
recent studies on the motility of T. gondii and its 
mechanisms of invasion of host cells, many blind spots 
 
Figure 3. TgPP2C inhibited HeLa cell apoptosis. (A) Flow cytometry analysis of the cell death rate in 
HeLa cells expressing HA-TgPP2C revealed by Alexa Fluor 488 Annexin-V/PI staining. HeLa cells were 
transiently transfected with HA-vector or HA-TgPP2C plasmids. After 48 h of the expression of these 
plasmids, the cells were harvested and stained with Alexa Fluor 488 Annexin-V/PI to analyze the death 
rate using a FACS Calibure flow cytometer. (B) The average cell death rate analysis of three repeated 
experiments. The data were shown as mean±SEM. 
**
: P<0.05. 
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remain to be enlightened regarding the whole life 
cycle of the parasite, particularly the strategy and 
mechanism used by the parasite to control its 
latency and replication in host cells. More 
importantly, a recent study, using a new technique 
to knock out individually each of the parasitic genes 
considered to be critical for parasite invasion, 
indicated that the knocking out of none of these 
genes could affect the invasion ability of the 
parasite
[30]
. This study raises doubts about current 
strategies of drug development aiming to block the 
parasite invasion, and highlight the importance of 
searching alternative ways to combat the parasite 
infection.  
One common response of host to parasite 
infection from viruses, bacteria, and eukaryotic 
pathogens, is apoptosis, which allows to eliminate 
the infectious agents rapidly by macrophages
[17]
. On 
 
 
Figure 4. TgPP2C inhibited DRB-induced cell apoptosis and interacted with SSRP1. (A) Western blotting 
analysis of the levels of cleaved Caspase-3 in HA-TgPP2C-expressed and/or DRB (100 μmol/L)-treated 
HeLa cells. Cleaved Cas-3/GAPDH values indicated at the bottom of the figure represent the ratio 
between the gray values of Cleaved Cas-3 and GAPDH protein bands. (B) Flow cytometry analysis of the 
cell death rate after DRB treatment in HeLa cells expressing HA-vector or HA-TgPP2C. HeLa cells 
transiently transfected with HA-vector or HA-TgPP2C plasmids were treated with DRB (100 μmol/L) for 
6 h. After trypsin/EDTA harvest and PBS washes, the cells were stained with Alexa Fluor 488 
Annexin-V/PI to analyze the death rate using a FACS Calibure flow cytometer. (C) The average cell death 
rate analysis of three repeated experiments. The data were shown as mean±SEM. 
***
: P<0.01. (D) 
His-tag pull-down assay analyzed the interaction of TgPP2C with SSRP1 after DRB (100 μmol/L) 
treatment. The control untreated HeLa cells or DMSO-, DRB-treated HeLa cells were incubated with 
Ni-NTA Superflow beads alone or with Ni-NTA beads coated with His-TgPP2C for 4 h at 4 °C. After brief 
centrifugation, the beads were washed, resuspended and boiled in SDS-PAGE sample buffer. Then, the 
pull-down fractions, together with the lysates (Lysates) were analyzed by Western blotting with SSRP1 
antibody. SSRP1/His-TgPP2C values indicated at the bottom of the figure represent the ratio between 
the gray values of SSRP1 pulled down and recombinant His-TgPP2C used. The recombinant His-TgPP2C 
was stained with CBB. 
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the other hand, it has been shown that the 
microorganisms including T. gondii protect host cell 
from apoptosis induced by a wide range of apoptotic 
inducers which may provide the possibility of 
survival for parasite in host cells facilitating its 
replication or latent infection
[15-16]
. T. gondii has 
been suggested to establish an anti-apoptotic 
condition in a variety of cell types through regulation 
of several signal pathways with its kinases and a 
phosphatase
[17]
. Previous reports showed that 
Toxoplasma prevented its host cells from apoptosis 
via promotion of NF-κB-dependent expression of 
anti-apoptotic genes
[31-32]
. The host cells infected 
with T. gondii exhibit a reduced activation of the 
caspase cascade after induction of apoptosis, 
including the lower activation of caspase-8, 
caspases-9, and caspase-3
[33-35]
. Consistent with 
these results, in our study, the enforced expression 
of phosphatase TgPP2C of T. gondii reduced the 
amount of cleaved caspase-3 in DRB-treated HeLa 
cells (Figure 4A), indicating the decreased activation 
of caspase-3 and the anti-apoptotic role of TgPP2C in 
HeLa cells under the treatment of apoptotic inducer 
DRB. 
TgPP2C, as the most abundant serine threonine 
phosphatase of the parasite
[19]
, plays a very 
important role in the regulation of parasite 
growth
[19]
. Moreover, PP2C in other organisms have 
been shown to regulate cell survival and apoptosis
[4]
. 
These findings hint at a major function of this 
parasitic enzyme in the control of the parasite 
growth by regulation of the fate of host cells. During 
the process of parasite invasion, TgPP2C was 
released and translocated to the host nucleus
[18]
, 
suggesting a possible role of this protein linked to 
the host genome. In this context, the identification 
of SSRP1 by the present study as a TgPP2C 
interacting partner turns out to be very meaningful.  
SSRP1, by binding to DNA, can alter the 
structure of chromatin, and regulate the replication 
and repair of the host genome, as well as the 
expression of genes
[21]
. Furthermore, it is a substrate 
of CKII, a kinase regulating the cell survival and 
apoptosis
[29]
.  
Combining yeast Two-hybrid, with in vitro 
pull-down assay, and co-immunoprecipitation, we 
clearly demonstrated that TgPP2C interacted with 
SSRP1 (Figures 1 and 2), and that the expression of 
TgPP2C reduced the DRB-induced cell apoptosis 
(Figure 4). The inhibitory effect of TgPP2C on 
DRB-induced cell apoptosis might be mediated by 
the direct interaction between TgPP2C and SSRP1, 
which could offset the inhibitory effect of DRB on 
the phosphorylation of SSRP1 by CKII. On the other 
hand, the effect of TgPP2C on cell apoptosis is not 
specific to DRB treatment, since it could also be 
observed in cell non-treated with DRB, although in a 
more moderate extent (Figure 3). Therefore, the 
action of TgPP2C might not be related specifically to 
the regulation of the SSRP1 phosphorylation by CKII. 
Instead, the interaction of TgPP2C with SSRP1 might 
exert an effect similar to that by CKII 
phosphorylation on SSRP1, which is to enhance the 
binding of the latter to damaged DNA and facilitate 
the DNA repair. Alternatively, TgPP2C-SSRP1 
interaction may also modulate the binding of SSRP1 
to DNA and regulate the expression of genes 
involved in cell survival and apoptosis. Figure 5 is a 
schematic presentation of our hypothesis. Future 
studies should aim to elucidate the precise 
mechanism by which TgPP2C-SSRP1 interaction is 
involved in the inhibition of cell apoptosis. 
In conclusion, in the present study, we 
demonstrate that TgPP2C interacts with mammalian 
SSRP1 through a C-terminal domain (amino acids 
471-538) of the latter. Furthermore, TgPP2C 
negatively regulates HeLa cells apoptosis possibly by 
interacting with SSRP1 and enhancing its activity. 
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